Fluocinonide and Hospitalisation - a phase IV clinical study of FDA data

Summary:

Hospitalisation is reported as a side effect among people who take Fluocinonide (fluocinonide), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Xyrem, and have Cataplexy.

The phase IV clinical study analyzes which people have Hospitalisation when taking Fluocinonide. It is created by eHealthMe based on reports of 6,347 people who have side effects when taking Fluocinonide from the FDA, and is updated regularly.

What is Fluocinonide?

Fluocinonide has active ingredients of fluocinonide. It is often used in eczema. eHealthMe is studying from 6,385 Fluocinonide users. Check the latest studies of Fluocinonide.

What is Hospitalisation?

Hospitalisation is found to be associated with 1,716 drugs and 1,133 conditions by eHealthMe. Check the latest studies of Hospitalisation.

On Jul, 19, 2026

6,347 people reported to have side effects when taking Fluocinonide.
Among them, 37 people (0.58%) have Hospitalisation.

Could Fluocinonide cause Hospitalisation?

Among these 37 people:

How long have people been on Fluocinonide when they have Hospitalisation? *

What is the gender of people who have Hospitalisation when taking Fluocinonide? *

female: 65.71 %
male: 34.29 %

What is the age of people who have Hospitalisation when taking Fluocinonide? *

What are other drugs people take besides Fluocinonide? *

What are other side effects people have besides Hospitalisation? *

High Blood Pressure: 5 people, 13.51%
Brain Stem Stroke (rapid loss of brain function due to disturbance in the blood supply to the brain): 5 people, 13.51%
Scar: 5 people, 13.51%
Weakness: 4 people, 10.81%
Juvenile Myoclonic Epilepsy (childhood epilepsy occurring early in morning affecting 12 to 18 years): 4 people, 10.81%
Loss Of Consciousness: 4 people, 10.81%
Dizziness: 4 people, 10.81%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 10.81%
Heart Rate Increased: 3 people, 8.11%
Nausea And Vomiting: 3 people, 8.11%

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 10 people, 27.03%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 10 people, 27.03%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 7 people, 18.92%
High Blood Pressure: 5 people, 13.51%
Asthma: 5 people, 13.51%
High Blood Cholesterol: 4 people, 10.81%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 8.11%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 5.41%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 5.41%
Neoplasm Malignant (cancer tumour): 1 person, 2.70%

* Approximation only. Some reports may have incomplete information.

Do you take Fluocinonide and have Hospitalisation?

- Check whether Hospitalisation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fluocinonide:

Fluocinonide (6,385 reports)

Hospitalisation treatments and more:

Hospitalisation (143,651 reports)

Browse all side effects of Fluocinonide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hospitalisation:

Hospitalisation (1,716 drugs)

Browse all the conditions that are associated with Hospitalisation:

Hospitalisation (1,133 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fluocinonide (the active ingredients of Fluocinonide) and Fluocinonide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.